Graupera, Isabel; Thiele, Maja; Ma, Ann T. et al.
LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries (vol 22, 1385, 2022)BMC PUBLIC HEALTH. Bd. 23. H. 1. 2023
Biller, Beverly M. K.; Hoybye, Charlotte; Ferran, Jean-Marc et al.
Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWERJOURNAL OF THE ENDOCRINE SOCIETY. Bd. 7. H. 6. 2023
Weimer, Johannes Matthias; Widmer, Nina; Strelow, Kai-Uwe et al.
Long-Term Effectiveness and Sustainability of Integrating Peer-Assisted Ultrasound Courses into Medical School-A Prospective StudyTOMOGRAPHY. Bd. 9. H. 4. 2023 S. 1315-1328
Dietz, Julia; Muellhaupt, Beat; Buggisch, Peter et al.
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failureJOURNAL OF HEPATOLOGY. Bd. 78. H. 1. 2023 S. 57-66
Michel, Maurice; Hagstrom, Hannes; Widman, Linnea et al.
LOWER INCIDENCE OF HCC AND OTHER MAJOR ADVERSE LIVER OUTCOMES IN PEOPLE LIVING WITH HIV AND CHRONIC LIVER DISEASE: A POPULATION-BASED COHORT STUDYHEPATOLOGY. Bd. 78. 2023 S. S395-S396
Weinmann-Menke, Julia
Lupus nephritis: from diagnosis to treatmentINNERE MEDIZIN. 2023
Lee, Jenny; Westphal, Max; Vali, Yasaman et al.
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation studyHEPATOLOGY. Bd. 78. H. 1. 2023 S. 258-271
Schepers, Markus; Schmidtmann, Irene; Zahn, Daniela et al.
Medical appointments and provision of medical care during the COVID-19 pandemic in Mainz, GermanyPLOS ONE. Bd. 18. H. 1. 2023
Schattenberg, Joern M.; Dubourg, Julie; Harrison, Stephen A. et al.
METABOLIC CONTROL WORSENS WITH INCREASING FIBROSIS STAGE IN PATIENTS WITH PRE-CIRRHOTIC NONALCOHOLIC STEATOHEPATITIS (NASH): COMBINED DATA FROM MULTIPLE THERAPEUTIC CLINICAL TRIALS INCLUDING MORE THAN 6,000 PATIENTS (WITH THE COLLABORATION OF NAIL-NIT CONSORTIUM)HEPATOLOGY. Bd. 78. 2023 S. S1006-S1009
Michel, Maurice; Labenz, Christian; Armandi, Angelo et al.
Metabolic dysfunction-associated fatty liver disease in people living with HIVSCIENTIFIC REPORTS. Bd. 13. H. 1. 2023